Cite

HARVARD Citation

    Seitaridou, Y. et al. (2022). Analysis of patients' access to reimbursed biotechnological medicines for multiple sclerosis in Bulgaria and Greece. Expert review of pharmacoeconomics & outcomes research. pp. 241-246. [Online]. 
  
Back to record